FDA Panel Votes Against PMA for Barricaid Anular Closure

FDA's Orthopaedic and Rehabilitation Devices Panel recommended against Premarket Approval of Intrinsic Therapeutics' Barricaid Anular Closure Device for partial anulus replacement to treat herniated discs.

The panel voted 5 to 9 that the device is safe, 12 to 1 (with 1 abstaining) that it is effective in patients for whom it is indicated,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us